Clinical trials
Phase 1 trials in France with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| Gustave Roussy, Cancer Campus, Grand Paris | 3 |
| Nantes University Hospital | 3 |
| University Hospital, Grenoble | 3 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Institut Paoli-Calmettes | 2 |
| Adlai Nortye Biopharma Co., Ltd. | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Georges Francois Leclerc | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 4 |
| Neoplasms | 3 |
| Astrocytoma | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Glioblastoma | 2 |
| Melanoma | 2 |
| Recurrence | 2 |
| Uterine Cervical Neoplasms | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.